SERUM ADALIMUMAB TROUGH LEVELS REQUIRED FOR ENDOSCOPIC MUCOSAL HEALING DURING MAINTENANCE THERAPY OF CROHN'S DISEASE

被引：1
|
作者：
Imaeda, Hirotsugu
Nishino, Kyohei
Ohno, Masashi
Nishida, Atsushi
Sugimoto, Mitsushige
Andoh, Akira
机构：
来源：
GASTROENTEROLOGY | 2017年 / 152卷 / 05期
关键词：
D O I：
10.1016/S0016-5085(17)31553-6
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Sa1918
引用
收藏
页码：S393 / S393
页数：1
相关论文
共 50 条
  • [31] HIGHER INFLIXIMAB AND ADALIMUMAB TROUGH LEVELS ARE ASSOCIATED WITH FISTULA HEALING IN PATIENTS WITH FISTULISING PERIANAL CROHN'S DISEASE
    Gu, Bonita
    Venkatesh, Kavya
    Williams, Astrid-Jane
    Ng, Watson
    Corte, Crispin
    Simon, Ghaly
    Xuan, Wei
    Paramsothy, Sudarshan
    Connor, Susan J.
    GASTROENTEROLOGY, 2020, 158 (06) : S467 - S468
  • [32] Higher infliximab and adalimumab trough levels are associated with fistula healing in patients with fistulising perianal Crohn's disease
    Gu, B.
    Venkatesh, K.
    Williams, A. J.
    Ng, W.
    Corte, C.
    Ghaly, S.
    Xuan, W.
    Paramsothy, S.
    Connor, S.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S490 - S491
  • [33] HIGHER INFLIXIMAB AND ADALIMUMAB TROUGH LEVELS ARE NOT ASSOCIATED WITH FISTULA HEALING IN PATIENTS WITH FISTULISING PERIANAL CROHN'S DISEASE
    Gilbert, Lauren E.
    Cheung, Wa
    Gerstenmaier, Jan F.
    Martin, Catherine A.
    Sparrow, Miles
    GASTROENTEROLOGY, 2019, 156 (06) : S112 - S112
  • [34] Maintenance Q8 therapy of Crohn's disease with infliximab is associated with endoscopic mucosal healing in the long-term
    Schnitzler, Fabian
    Fidder, Herma
    Ferrante, Marc
    Noman, Maja
    Van Assche, Gert A.
    Hoffman, Ilse
    Vermeire, Severine
    Rutgeerts, Paul J.
    GASTROENTEROLOGY, 2008, 134 (04) : A133 - A133
  • [35] Higher Adalimumab Trough Levels Are Associated with Histologic Remission and Mucosal Healing in Inflammatory Bowel Disease
    Wong, Rochelle
    Qin, Lihui
    Pan, Yushan
    Mahtani, Prerna
    Longman, Randy
    Lukin, Dana
    Scherl, Ellen
    Battat, Robert
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (21)
  • [36] Association of Infliximab Levels With Mucosal Healing Is Time-Dependent in Crohn's Disease: Higher Drug Exposure Is Required Postinduction Than During Maintenance Treatment
    Feng, Ting
    Chen, Baili
    Ungar, Bella
    Qiu, Yun
    Zhang, Shenghong
    He, Jinshen
    Lin, Sinan
    He, Yao
    Zeng, Zhirong
    Ben-Horin, Shomron
    Chen, Minhu
    Mao, Ren
    INFLAMMATORY BOWEL DISEASES, 2019, 25 (11) : 1813 - 1821
  • [37] Higher Ustekinumab Levels in Maintenance Therapy are Associated with Greater Mucosal Healing and Mucosal Response in Crohn's Disease: An Experience of 2 IBD Centers
    McDonald, Ciaran
    Kerr, Hilary
    Gibbons, Eimear
    Lukose, Tincymol
    Cheriyan, Danny
    Harewood, Gavin
    Patchett, Stephen
    O'Toole, Aoibhlinn
    Kelly, Orlaith
    Boland, Karen
    INFLAMMATORY BOWEL DISEASES, 2024, 30 (03) : 423 - 428
  • [38] Adalimumab trough serum levels and anti-adalimumab antibodies in the long-term clinical outcome of patients with Crohn's disease
    Bodini, Giorgia
    Giannini, Edoardo G.
    Savarino, Vincenzo
    Del Nero, Lorenzo
    Pellegatta, Gaia
    De Maria, Costanza
    Baldissarro, Isabella
    Savarino, Edoardo
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2016, 51 (09) : 1081 - 1086
  • [39] Association of Infliximab trough levels and transmural healing in Crohn's disease
    Bernardo, S.
    Fernandes, S.
    Simoes, C.
    Goncalves, A. R.
    Baldaia, C.
    Valente, A.
    Moura Santos, P.
    Correia, L.
    Marinho, R.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S336 - S337
  • [40] Predictive Factors for Mucosal Healing in Crohn's Disease Patients With Unelevated Serum CRP Levels
    Nakarai, Asuka
    Hiraoka, Sakiko
    Kato, Jun
    Inokuchi, Toshihiro
    Akita, Mitsuhiro
    Hirakawa, Tomoko
    Hori, Keisuke
    Harada, Keita
    Okada, Hiroyuki
    Yamamoto, Kazuhide
    GASTROENTEROLOGY, 2013, 144 (05) : S776 - S776
12345